This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Juergen Mueller, PhD
Vice President of Commercial Operations at LGC Axolabs


Juergen is currently Vice President Commercial Operations at Axolabs (a LGC company) while having all clinical service programs up to commercial stage under his responsibility. The reach is worldwide since Axolabs serves clients in the EU, US (North America including Canada and South America) and APAC region, covering Project Management, Marketing & Sales. Juergen spend more than >20 years in the Life Science industry while having held senior management positions in BD, Sales and Marketing, Licensing and Project Management from Fortune 500 companies, such as Sigma-Aldrich (US), up to leading service providers as Solvias (Switzerland), and top Oligo CMO’s as Nitto-Avecia (US/Jpn). Author and inventor of >40 peer reviewed scientific articles and patents.

Agenda Sessions

  • Addressing Complex Oligonucleotide Therapeutics and Approach Towards Endotoxin Removal